These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New therapeutic strategies targeting transmembrane signal transduction in the immune system. Sigalov AB Cell Adh Migr; 2010; 4(2):255-67. PubMed ID: 20519929 [TBL] [Abstract][Full Text] [Related]
6. Evolution of immunity: no development without risk. Sigalov AB Immunol Res; 2012 Jun; 52(3):176-81. PubMed ID: 22095544 [TBL] [Abstract][Full Text] [Related]
7. Interplay between protein order, disorder and oligomericity in receptor signaling. Sigalov AB Adv Exp Med Biol; 2012; 725():50-73. PubMed ID: 22399318 [TBL] [Abstract][Full Text] [Related]
8. Protein intrinsic disorder and oligomericity in cell signaling. Sigalov AB Mol Biosyst; 2010 Mar; 6(3):451-61. PubMed ID: 20174674 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Intrinsic Disorder Analysis of 6108 Viral Proteomes: From the Extent of Intrinsic Disorder Penetrance to Functional Annotation of Disordered Viral Proteins. Kumar N; Kaushik R; Tennakoon C; Uversky VN; Longhi S; Zhang KYJ; Bhatia S J Proteome Res; 2021 May; 20(5):2704-2713. PubMed ID: 33719450 [TBL] [Abstract][Full Text] [Related]
11. The SCHOOL of nature: II. Protein order, disorder and oligomericity in transmembrane signaling. Sigalov AB Self Nonself; 2010 Apr; 1(2):89-102. PubMed ID: 21487511 [TBL] [Abstract][Full Text] [Related]
12. Intrinsic Disorder in Transmembrane Proteins: Roles in Signaling and Topology Prediction. Bürgi J; Xue B; Uversky VN; van der Goot FG PLoS One; 2016; 11(7):e0158594. PubMed ID: 27391701 [TBL] [Abstract][Full Text] [Related]
13. Intrinsic disorder in the Protein Data Bank. Le Gall T; Romero PR; Cortese MS; Uversky VN; Dunker AK J Biomol Struct Dyn; 2007 Feb; 24(4):325-42. PubMed ID: 17206849 [TBL] [Abstract][Full Text] [Related]
14. Functional unfoldomics: Roles of intrinsic disorder in protein (multi)functionality. Uversky VN Adv Protein Chem Struct Biol; 2024; 138():179-210. PubMed ID: 38220424 [TBL] [Abstract][Full Text] [Related]
17. Transmembrane interactions as immunotherapeutic targets: lessons from viral pathogenesis. Sigalov AB Adv Exp Med Biol; 2007; 601():335-44. PubMed ID: 17713022 [TBL] [Abstract][Full Text] [Related]
18. Membrane-enabled dimerization of the intrinsically disordered cytoplasmic domain of ADAM10. Deng W; Cho S; Su PC; Berger BW; Li R Proc Natl Acad Sci U S A; 2014 Nov; 111(45):15987-92. PubMed ID: 25349418 [TBL] [Abstract][Full Text] [Related]
19. An overview of the sequence features of N- and C-terminal segments of the human chemokine receptors. Raucci R; Costantini S; Castello G; Colonna G Cytokine; 2014 Dec; 70(2):141-50. PubMed ID: 25138014 [TBL] [Abstract][Full Text] [Related]